Relief Therapeutics Holding AG (RLFTF)

[Pcilliterate]

Relax. We are good.





"A randomized placebo-controlled trial of Aviptadil is underway that has enrolled more than 130 patients. In that trial, no drug-related serious adverse effects were seen and an independent data safety board determined that the trial should continue with a clear possibility that a difference between RLF-100 and placebo will be seen."

https://clinicaltrials.gov/ProvidedDocs/39/NCT04453839/ICF_002.pdf